162 related articles for article (PubMed ID: 7517173)
21. Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux.
Servidei T; Iavarone A; Lasorella A; Mastrangelo S; Riccardi R
Eur J Cancer; 1995; 31A(4):591-5. PubMed ID: 7576975
[TBL] [Abstract][Full Text] [Related]
22. HBO and the uptake and retention of [125I] MIBG in human platelets and two neuroendocrine cell lines.
Tytgat GA; Cornelissen J; Van den Brug M; Van Kuilenburg AB; Voute PA; Van der Kleij AJ; Van Gennip AH
Anticancer Res; 1997; 17(2A):1209-12. PubMed ID: 9137473
[TBL] [Abstract][Full Text] [Related]
23. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
Smets LA; Rutgers M
J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
[No Abstract] [Full Text] [Related]
24. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
Cunningham SH; Mairs RJ; Wheldon TE; Welsh PC; Vaidyanathan G; Zalutsky MR
Br J Cancer; 1998 Jun; 77(12):2061-8. PubMed ID: 9649115
[TBL] [Abstract][Full Text] [Related]
25. Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
Batra V; Makvandi M; Zuppa AF; Patel N; Elias J; Pryma DA; Maris JM
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27654664
[TBL] [Abstract][Full Text] [Related]
26. gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells.
Montaldo PG; Carbone R; Ponzoni M; Cornaglia-Ferraris P
Cancer Res; 1992 Sep; 52(18):4960-4. PubMed ID: 1325288
[TBL] [Abstract][Full Text] [Related]
27. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
[TBL] [Abstract][Full Text] [Related]
28. Meta-iodobenzylguanidine uptake in platelets, megakaryoblastic leukaemia cell lines MKPL-1 and CHRF-28-11 and erythroleukaemic cell line HEL.
Tytgat GA; Voƻte PA; Takeuchi S; Miyoshi I; Rutgers M
Eur J Cancer; 1995; 31A(4):603-6. PubMed ID: 7576978
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
30. The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.
Mairs RJ; Gaze MN; Barrett A
Br J Cancer; 1991 Aug; 64(2):293-5. PubMed ID: 1892758
[No Abstract] [Full Text] [Related]
31. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
32. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
Lashford LS; Hancock JP; Kemshead JT
Int J Cancer; 1991 Jan; 47(1):105-9. PubMed ID: 1985865
[TBL] [Abstract][Full Text] [Related]
33. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
Wafelman AR; Hoefnagel CA; Maessen HJ; Maes RA; Beijnen JH
Eur J Nucl Med; 1997 May; 24(5):544-52. PubMed ID: 9142736
[TBL] [Abstract][Full Text] [Related]
34. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.
Streby KA; Shah N; Ranalli MA; Kunkler A; Cripe TP
Pediatr Blood Cancer; 2015 Jan; 62(1):5-11. PubMed ID: 25175627
[TBL] [Abstract][Full Text] [Related]
35. Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.
Boyd M; Cunningham SH; Brown MM; Mairs RJ; Wheldon TE
Gene Ther; 1999 Jun; 6(6):1147-52. PubMed ID: 10455418
[TBL] [Abstract][Full Text] [Related]
36. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
Montaldo PG; Carbone R; Lanciotti M; Ponzoni M; Cornaglia-Ferraris P
J Nucl Biol Med (1991); 1991; 35(4):195-8. PubMed ID: 1823817
[TBL] [Abstract][Full Text] [Related]
37. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
Ott RJ; Tait D; Flower MA; Babich JW; Lambrecht RM
Br J Radiol; 1992 Sep; 65(777):787-91. PubMed ID: 1393416
[TBL] [Abstract][Full Text] [Related]
38. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR
Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
Babich JW; Graham WA; Fischman AJ
Br J Cancer; 1996 Sep; 74(6):917-24. PubMed ID: 8826858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]